Frederik Wenz is an expert in Radiotherapy at University Medical Center Freiburg (Germany). As of August 2026, ScienceLeadR ranks Frederik Wenz in the top 1% of experts worldwide for Breast Diseases and Breast Neoplasms. Frederik Wenz has authored 772 publications, the most recent in 2026, and is an investigator in 16 clinical trials. SLR score: 2,166 (community average: 125). How the SLR is computed.

LeadR Profile

2 166 ScienceLeadR Reputation 2166
Network Map

Radiotherapy

Subspecialties: Oncology - Surgery

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1993 - 2026

Source: PubMed

University Medical Center Freiburg

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 772

Citations

Citations: 22 333 1st author: 43 Last author: 199 Unique author: 11


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Dose escalation with intraoperative radiotherapy in newly diagnosed glioblastoma (INTRAGO-II): an open-label, multicentre, randomised, controlled, phase 3 trial.
PMID 42372746 — radiotherapy, lung, progression-free survival, temozolomide, neoplasms, drug-related side effects and adverse reactions, glioblastoma, therapeutics, infections
Lancet Oncol Top journal20264
Long-term cosmetic outcome after intraoperative radiotherapy boost with low-energy X-rays in breast-conserving therapy: a pooled cohort analysis of the TARGIT-BQR and ROKSM trials.
PMID 41627394 — radiotherapy, neoplasms, breast, therapeutics
Strahlenther Onkol20260
Intraoperative radiotherapy in elderly patients with breast cancer: long-term follow-up results of the prospective phase II trial TARGIT-E.
PMID 41345599 — radiotherapy, breast neoplasms, fibrosis, pain, neoplasms, aged, breast, therapeutics
BMC Cancer20250
Oncological outcomes of breast cancer patients after planned IORT boost with low-kV x-rays-results of the TARGIT BQR prospective phase IV trial.
PMID 40387868 — radiotherapy, lymph nodes, breast neoplasms, neoplasms, neoplasm metastasis, lymph, breast
Strahlenther Onkol20250
[Reform proposal "Occasional surgical oncology" : Medical strategic analysis and ramifications of the draft bill within the framework of the Hospital Treatment Improvement Act (KHVVG) from the perspective of a university hospital].
PMID 39143420 — surgical oncology, therapeutics, medical oncology, universities
Chirurgie (Heidelb)20244

Clinical Studies 16

Sources: ClinicalTrials, EU CTIS

Synthesis

Study Chair: 2

By phase:

Phase 3 8
N/A 4
Phase 2 2
Phase 1 1
Phase 1/Phase 2 1

By status:

Completed 12
Active not recruiting 1
Terminated 1
Unknown 1
Withdrawn 1

By type:

Interventional 15
Observational 1

By Monocentric/Multicentric:

monocentric 9
multicentric2to4 2
multicentric5to9 0
multicentricup10 5

Main Topics

Cohort/Consortium Investigators 1

LeadR Networks

Main global connection map